Cleared Traditional

K833396 - C-PEPTIDE RADIOIMMUNOASSAY TEST KIT

K833396 is the FDA 510(k) clearance for C-PEPTIDE RADIOIMMUNOASSAY TEST KIT by Serono Diagnostics, Inc.. It is a Class 1 Chemistry device (product code JKD) cleared through the Traditional 510(k) pathway after a 196-day FDA review.

K833396 · Serono Diagnostics, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 1984
Decision
196d
Days
Class 1
Risk

K833396 is an FDA 510(k) clearance for the C-PEPTIDE RADIOIMMUNOASSAY TEST KIT. Classified as Radioimmunoassay, C-peptides Of Proinsulin (product code JKD), Class I - General Controls.

Submitted by Serono Diagnostics, Inc. (Walker, US). The FDA issued a Cleared decision on April 13, 1984 after a review of 196 days - an extended review cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1135 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Serono Diagnostics, Inc. devices

Submission Details

510(k) Number K833396 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 30, 1983
Decision Date April 13, 1984
Days to Decision 196 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
108d slower than avg
Panel avg: 88d · This submission: 196d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code JKD Radioimmunoassay, C-peptides Of Proinsulin
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1135
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - JKD Radioimmunoassay, C-peptides Of Proinsulin

Devices cleared under the same product code (JKD) and FDA review panel - the closest regulatory comparables to K833396.
IMMULITE C-PEPTIDE
K943767 · Diagnostic Products Corp. · Mar 1995
DSL C-PEPTIDE RIA (DSL #7000)
K896420 · Diagnostic Systems Laboratories, Inc. · May 1990
DOUBLE ANTIBODY C-PEPTIDE RIA KIT
K854066 · Diagnostic Products Corp. · Nov 1985
RIA QUANT C-PEPTIDE KIT
K812689 · Mallinckrodt Critical Care · Oct 1981
C-PEPTICE REAGENTS
K810718 · Calbiochem-Behring Corp. · Mar 1981